Therapeutic Targeting of the Cancer Microbiome and Metabolome: Ongoing Trials and Future Directions for the Surgical Oncologist

Erika J. Nachman, Taylor Neilson, Michael G. White

Open source

DOI
10.1002/jso.70451
Published
2026-11-09
Container
Journal of Surgical Oncology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jso.70451,
  title = {Therapeutic Targeting of the Cancer Microbiome and Metabolome: Ongoing Trials and Future Directions for the Surgical Oncologist},
  author = {Erika J. Nachman and Taylor Neilson and Michael G. White},
  year = {2026},
  journal = {Journal of Surgical Oncology},
  doi = {10.1002/jso.70451},
  url = {https://doi.org/10.1002/jso.70451}
}

RIS

TY  - JOUR
TI  - Therapeutic Targeting of the Cancer Microbiome and Metabolome: Ongoing Trials and Future Directions for the Surgical Oncologist
AU  - Erika J. Nachman
AU  - Taylor Neilson
AU  - Michael G. White
PY  - 2026
JO  - Journal of Surgical Oncology
DO  - 10.1002/jso.70451
UR  - https://doi.org/10.1002/jso.70451
ER  - 

APA

Nachman, E. J., Neilson, T., & White, M. G. (2026). Therapeutic Targeting of the Cancer Microbiome and Metabolome: Ongoing Trials and Future Directions for the Surgical Oncologist. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70451

Source records